Phase 3 Gastroparesis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with gastroparesis (a condition where the stomach empties food more slowly than normal)
- Tests have confirmed that your stomach empties more slowly than it should
- You experience moderate to severe nausea
- Your Body Mass Index (BMI) is between 18 and 40 (a measure of body weight relative to height)
Who may not be able to join:
- You have another condition or are receiving a treatment that could be causing or adding to your stomach symptoms
- A drug screening test at your initial appointments shows the presence of non-prescribed or recreational drugs
- You are currently pregnant or breastfeeding
- Your blood sugar levels are not well controlled, including having a specific blood sugar marker (HbA1c) above 11% at your first appointment, or having had a serious blood sugar-related health crisis in the past 60 days
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Vanda Pharmaceuticals, Vanda Pharmaceuticals
Phone: 202-734-3400
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants with adverse events (AEs), including suicidal ideation or behavior as measured by the C-SSRS; Number of participants with changes in vital signs identified as Clinically Notable Abnormal values; Number of participants with abnormal and potentially Clinically Notable Abnormal Electrocardiogram Intervals and Heart Rate; Number of participants with Clinically Notable Abnormal laboratory values
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.